Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-28 @ 12:45 PM
Study NCT ID:
NCT00951457
Status:
COMPLETED
Last Update Posted:
2022-03-03
First Post:
2009-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2012-08-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-03
First Submit QC Date:
None
Study First Post Date:
2009-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-03-03
Last Update Post Date Type:
ACTUAL